• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

33 Charts

  • About
    • What is 33 Charts?
    • Bryan Vartabedian MD
  • Blog
  • 33mail
  • Foci
    • Social/Public Media
    • Physicians
    • Patients
    • Hospitals
    • Information
    • Process/Flow
    • Technology
    • Digital culture
    • Future Medicine
  • The Public Physician
Physicians

Pharma Names Doctors – Now What?

December 30, 2009 By Bryan Vartabedian · Reading Time: < 1 minutes

This was the year that Pharma names doctors. They have disclosed the names and payments of their physician consultants. Look here for physicians speaking and consulting with Merck, GlaxoSmithKline, Lilly, and Pfizer.

Physician disclosure of conflict is important. It helps put a physician’s opinion and point of view into a context. Disclosure has long been the standard in the academic world. This represents the first time that such information has been made available to the general public.

But how will patients use this information and how will it affect care and outcomes?  Should patients flatly avoid physicians or others who have a relationship with a pharmaceutical company?  And should patients routinely screen physicians for conflict?

I don’t know the answer to these questions. I’m not sure patients know the answer to these questions. I suspect patients may not like the idea but would be willing to overlook a pharma connection when the reputation of the physician is impeccable.

Transparency is all the rage. Expect more. But I’m wondering how the average health consumer will practically process the information.

If you like Pharma Names Doctors then you might like our Pharma/Industry archive. This archive covers writing that deals with doctors, pharma and technology.

Related Articles

  • Can Pharma Detail Doctors Digitally?
  • Online Doctors
  • Doctors, Patients and Boundaries

Tagged With: Pharma/Industry

Related Articles

  • Can Pharma Detail Doctors Digitally?
  • Online Doctors
  • Doctors, Patients and Boundaries

Primary Sidebar

Bryan Vartabedian, MD

Bryan Vartabedian, MD
Bryan Vartabedian is the Chief Pediatrics Officer at Texas Children’s Hospital North Austin and one of health care’s influential
voices on technology & medicine.
Learn More

Popular Articles

  • The Fate of Fired Cleveland Clinic Resident Lara Kollab
  • Cures Act Final Rule – How It Will Change Medicine
  • 12 Things About Doximity You Probably Didn’t Know
  • Should Physicians Give Their Cell Phone Number to Patients?
  • Doximity Dialer Video – Telemedicine’s Latest Power Player

Sign up for 33mail newsletter

Featured Articles

Doctors and social media: Damned if you engage, damned if you don’t

Health Care and the Visibility-Value Continuum

Doctors and the Endemic Culture of Permission

The Rise of Medicine’s Creative Class

Reactive and Creative Spaces

  • Facebook
  • LinkedIn
  • Twitter

Footer

What is 33 Charts?

With a mashup of curated and original content that crosses the spaces of digital health, media, communication, technology, patient experience, digital culture, and the humanities, 33 charts offers unique insight and analysis on the changing face of medicine.

Founded in 2009 as a center of community and thought leadership for the issues doctors face in a digital world, 33 charts was included in the National Library of Medicine permanent web archive in 2014.
Learn More

Foci

  • Digital culture
  • Digital Health
  • EHR/Health IT
  • Future Medicine
  • Hospitals
  • Information
  • Patients
  • Physicians
  • Process/Flow
  • Quality
  • Social/Public Media
  • Technology

Copyright © 2023 · 33 Charts · Privacy Policy